Applovin Corporation Total Cost of Revenue increased by 11.0% to $203.63M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 34.3%, from $151.68M to $203.63M. Over 3 years (FY 2021 to FY 2025), Total Cost of Revenue shows a downward trend with a -12.4% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $245.85M | $254.05M | $265.13M | $281.78M | $303.93M | $300.99M | $369.37M | $261.96M | $258.58M | $265.05M | $294.15M | $121.76M | $120.92M | $153.39M | $151.68M | $155.08M | $174.86M | $183.53M | $203.63M |
| QoQ Change | — | +3.3% | +4.4% | +6.3% | +7.9% | -1.0% | +22.7% | -29.1% | -1.3% | +2.5% | +11.0% | -58.6% | -0.7% | +26.9% | -1.1% | +2.2% | +12.8% | +5.0% | +11.0% |
| YoY Change | — | — | — | — | +23.6% | +18.5% | +39.3% | -7.0% | -14.9% | -11.9% | +12.3% | -52.9% | -54.4% | — | -48.4% | +27.4% | +44.6% | +19.6% | +34.3% |